1. Home
  2. NEON vs CYTH Comparison

NEON vs CYTH Comparison

Compare NEON & CYTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEON
  • CYTH
  • Stock Information
  • Founded
  • NEON N/A
  • CYTH 1990
  • Country
  • NEON Sweden
  • CYTH United States
  • Employees
  • NEON N/A
  • CYTH N/A
  • Industry
  • NEON Industrial Machinery/Components
  • CYTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEON Technology
  • CYTH Health Care
  • Exchange
  • NEON Nasdaq
  • CYTH Nasdaq
  • Market Cap
  • NEON 37.5M
  • CYTH 35.5M
  • IPO Year
  • NEON 2007
  • CYTH N/A
  • Fundamental
  • Price
  • NEON $3.16
  • CYTH $1.15
  • Analyst Decision
  • NEON
  • CYTH Strong Buy
  • Analyst Count
  • NEON 0
  • CYTH 3
  • Target Price
  • NEON N/A
  • CYTH $3.20
  • AVG Volume (30 Days)
  • NEON 412.4K
  • CYTH 42.6K
  • Earning Date
  • NEON 08-08-2024
  • CYTH 08-12-2024
  • Dividend Yield
  • NEON N/A
  • CYTH N/A
  • EPS Growth
  • NEON N/A
  • CYTH N/A
  • EPS
  • NEON N/A
  • CYTH N/A
  • Revenue
  • NEON $4,210,000.00
  • CYTH $1,126,444.00
  • Revenue This Year
  • NEON $152.19
  • CYTH $28.30
  • Revenue Next Year
  • NEON N/A
  • CYTH $14.19
  • P/E Ratio
  • NEON N/A
  • CYTH N/A
  • Revenue Growth
  • NEON N/A
  • CYTH N/A
  • 52 Week Low
  • NEON $1.02
  • CYTH $0.89
  • 52 Week High
  • NEON $4.39
  • CYTH $2.12
  • Technical
  • Relative Strength Index (RSI)
  • NEON 64.08
  • CYTH 40.45
  • Support Level
  • NEON $2.82
  • CYTH $1.12
  • Resistance Level
  • NEON $3.45
  • CYTH $1.34
  • Average True Range (ATR)
  • NEON 0.25
  • CYTH 0.08
  • MACD
  • NEON 0.08
  • CYTH -0.01
  • Stochastic Oscillator
  • NEON 70.23
  • CYTH 10.71

About NEON Neonode Inc.

Neonode Inc provides optical sensing solutions for contactless touch, touch, and gesture sensing and also provides software solutions for machine perception that feature machine learning algorithms to detect and track persons and objects in video streams from cameras and other types of imagers. It markets and sells its solutions to customers in many different markets and segments including, but not limited to, office equipment, automotive, industrial automation, medical, military, and avionics. The company geographically operates in United States, Japan, South Korea, Germany, Switzerland, China, France, Sweden and Others. It derives maximum revenue from United States.

About CYTH Cyclo Therapeutics Inc.

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing cyclodextrin-based products for treating neurodegenerative diseases, particularly Niemann-Pick Type C disease (NPC). The company's lead drug candidate, Trappsol Cyclo, has undergone clinical trials for NPC treatment. Operating in one segment, the company focuses on developing and commercializing cyclodextrin-based treatments for rare diseases. Revenue primarily comes from selling cyclodextrins and related products to pharmaceutical and nutritional industries, with Trappsol HPB and Trappsol Fine Chemical being significant contributors.

Share on Social Networks: